Previous close | 0.9556 |
Open | 0.9800 |
Bid | 0.9343 x 3200 |
Ask | 0.9499 x 900 |
Day's range | 0.9343 - 0.9800 |
52-week range | 0.8100 - 5.6500 |
Volume | |
Avg. volume | 277,750 |
Market cap | 31.313M |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 1.66 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Kin Communications Inc. ("Kin"), a leading full-service investor relations agency, has joined forces with NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen M.D.''), a leader in needle-free drug delivery, to raise funds in order to purchase insulin to be administered and delivered with NuGen M.D's needle-free injection device also known as InsuJet™, to Ukrainian diabetics urgently in need of daily insulin injections to stay alive.
Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (
Today, the Drone Racing League (DRL), the world's premier, professional drone racing property, and Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8), an award-winning, industry-leading drone solutions and systems developer, announced a multi-year partnership. The companies will launch DRL Labs, an innovation hub, to research and develop next generation drone technology that will advance the sport of drone racing and other industries undergoing significant transformations through drones, includi